Loading clinical trials...
Loading clinical trials...
The purpose of this study is to describe the following in relation to the safety of Equfina Tablet 50 mg in the post marketing setting: 1. Serious adverse events (SAEs) and adverse drug reactions (ADR...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Eisai Korea Inc.
NCT06087926 · Parkinson Disease
NCT07642908 · Parkinson Disease
NCT06680830 · Parkinson Disease, Parkinson, and more
NCT05822388 · Parkinson Disease, Movement Disorders
NCT06965374 · Parkinson Disease
Site #23
Wŏnju, Gangwon-do
Site #11
Ilsan, Gyeonggi-do
Site #22
Yongin-si, Gyeonggi-do
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions